Navigation Links
Equine Obesity is Associated with Significant Health Issues, Including Insulin Resistance and Laminitis
Date:6/24/2009

Vet-A-Mix announces the release of an optimal nutritional supplement to support overall health and laminitis prevention for at-risk horses.

Shenandoah, IA (PRWEB) June 24, 2009 -- Equine obesity is on the rise in the United States. A large percentage of these horses are insulin resistant, and as such are at a higher risk for laminitis: a debilitating condition responsible for thousands of deaths each year. According to the USDA National Health Monitoring System, laminitis is the second most common reason for horses and ponies to present for veterinary care, yet 50% of these episodes can be prevented with effective nutritional management.

Vet-A-Mix, a Division of LLOYD, Inc. has recently introduced a simple and highly palatable solution for optimal dietary management of at-risk horses. The formula was developed in accordance to the Equine Cushing's and Insulin Resistance Group recommendations, and provides a complete, readily absorbable balance of vitamins, minerals, antioxidants and fatty acids ideal for the grass hay fed horse. Eleanor Kellon, VMD, a recognized expert in the field of horse nutrition, was instrumental in the final preparation. "We have found that careful attention to mineral balance and antioxidant nutrients in addition to controlled simple carbohydrates is both the safest and surest way to improve insulin resistance, control inflammation and regrow healthy hoof tissues." As the principal at Equine Nutritional Solutions (Ephrata, PA) and co-owner of the Equine Cushing's and Insulin Resistance Group Dr. Kellon consistently promotes properly balanced nutritional support, along with reduction in non-structural carbohydrates and increased exercise for these horses. "We are pleased to introduce Target IRTM to veterinarians and owners struggling to optimize the health of insulin resistant equids" states W. Eugene Lloyd, DVM, PhD, DABVT and CEO of LLOYD, Inc. "This clinically-validated formulation is poised to play a key role in helping to prevent laminitis and improving the quality and longevity of these horses."

For more information on equine insulin resistance, laminitis and related conditions, visit the Target IR webpage at: http://www.lloydinc.com/vet_equine_targetIR.html.

ABOUT LLOYD

LLOYD, Inc. (Shenandoah, IA), manufactures, tests and markets unique pharmaceutical and nutraceutical products for veterinary and human medicine. Working in partnership with more than forty distributors, LLOYD products can be found in virtually every veterinary clinic and school of veterinary medicine in the United States.

###

Read the full story at http://www.prweb.com/releases/2009/06/prweb2564574.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Worlds First Portable, Battery-Operated, Equine-Dedicated CT Solution Installed at Penn Vets New Bolton Center
2. ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention
3. Fish Oil Fueling Equine Olympians
4. Equine Partners in Counseling (EPIC) Training Is Changing the Face of Mental Health
5. AVMA Opposes Use of Double-Deck Trailers for Transporting Horses and Other Equines
6. Fort Dodge Animal Health and the American Association of Equine Practitioners Launch Educational Web Site
7. Turning Pointe Therapeutic Riding Recognized for Excellence in Providing Equine-Assisted Therapies to People with Disabilities
8. ASPCA Provides Funding for Hay, Equine Expenses Following Outbreak of California Wildfires
9. Bioniche Responds to Australian Equine Influenza Outbreak
10. Obesity While Young Boosts Pancreatic Cancer Risk
11. 21st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Petersburg Florida (PRWEB) , ... March 28, 2017 , ... ... Marine Corp to raise money to for the Toys for Tots Literacy Campaign at ... federal budget in excess of $70 billion, the U.S. ranks at number 14 internationally ...
(Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced ... American Association of Integrative Medicine and available for application on Saturday, May 27, ... 2017 Conference in Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many ...
(Date:3/28/2017)... ... March 28, 2017 , ... The ... in Atlantic City March 13-16, was a busy spot this year. Liz Solovay ... discussed strategies for preventing outbreaks among camp communities during the upcoming 2017 camping ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
(Date:3/28/2017)... ... ... thrilling adventure that reveals the mystery of Kevin’s purpose. “A Prophets Bones” is the creation ... asked of him that he had neglected to do, but this was from God and ... some who would have felt themselves to be special and better than others due to ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... BOSTON , March 28, 2017 /PRNewswire/ ... today announced a partnership with premium news ... allows pharmaceutical companies to extract key insights from ... text mining technology. The Linguamatics I2E ... top 20 global pharmaceutical companies. The Linguamatics-Dow Jones ...
(Date:3/28/2017)...  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: ... directors: Christopher Gabrieli , ... as chairman of the board of Akcea Therapeutics. ... Forest Laboratories. Sandford D. Smith , ... "We are excited to announce this expansion to our ...
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
Breaking Medicine Technology: